Masking the Bitter Taste of Injectable Lidocaine HCl Formulation for Dental Procedures

AAPS PharmSciTech

Volumn 16, Issue 2, 2014, Pages 455-465

  Wei, Yangjie ^a   Nedley, Michael P ^b   Bhaduri, Sarit B ^c   Bredzinski, Xavier ^d   Boddu, Sai H S ^a  

^a UNIVERSITY OF TOLEDO   (United States)

^b MEDICAL COLLEGE OF OHIO   (United States)

^c The University of Toledo   (United States)

^d Alpha MOS   (United States)

Author keywords

bitter taste; HP CD; inclusion complex; injectable; lidocaine HCl; taste masking

Indexed keywords

2-HYDROXYPROPYL-BETA-CYCLODEXTRIN; BETA CYCLODEXTRIN DERIVATIVE; LIDOCAINE; SACCHARIN;

CHEMISTRY; DENTAL ANESTHESIA; DRUG FORMULATION; INJECTION; MEDICINAL CHEMISTRY; PROCEDURES; SOLUBILITY; TASTE;

ANESTHESIA, DENTAL; BETA-CYCLODEXTRINS; CHEMISTRY, PHARMACEUTICAL; DRUG COMPOUNDING; INJECTIONS; LIDOCAINE; SACCHARIN; SOLUBILITY; TASTE;

EID: 84939979320     PISSN: None     EISSN: 15309932     Source Type: Journal    
DOI: 10.1208/s12249-014-0239-z     Document Type: Article

References (44)

1. Pipa-Vallejo A, Garcia-Pola-Vallejo MJ. Local anesthetics in dentistry. Med Oral Patol Oral y Cir Bucal. 2004;9(5):440–3.
2. Covino BG, Vassallo HG. Local anesthetics: mechanisms of action and clinical use: Grune & Stratton; 1976.
3. Malamed SF. Handbook of local anesthesia: Mosby-Year Book; 1997.
4. Ram D, Amir E. Comparison of articaine 4% and lidocaine 2% in paediatric dental patients. International journal of paediatric dentistry/the British Paedodontic society [and] the international association of dentistry for. Child. 2006;16(4):252–6.
5. Wilson S. Pharmacologic behavior management for pediatric dental treatment. Pediatr Clin N Am. 2000;47(5):1159–75.
6. Naini FB, Mellor AC, Getz T. Treatment of dental fears: pharmacology or psychology? Dent Updat. 1999;26(7):270–46.
7. Ten Berge M. Dental fear in children: clinical consequences suggested behaviour management strategies in treating children with dental fear. Eur Arch Paediatr Dent. 2008;9(1):41–6.
8. ADAMS DS. Compositions and methods for masking taste. Google Patents; 2013.
9. Zelaya LM. Oral rinse composition. Google Patents; 1994.
10. Rosenbaum RJ. Sweet analgesic for use in medical procedures or treatments. Google Patents; 2011.
11. Wall TP, Vujicic M, Nasseh K. Recent trends in the utilization of dental care in the United States. J Dent Educ. 2012;76(8):1020–7.
12. Vujicic M, Goodell S, Nasseh K. Dental benefits to expand for children, likely decrease for adults in coming years. Health Policy Resources Center Research Brief American Dental Association. 2013.
13. Brunetto PC, Ranali J, Bovi Ambrosano GM, de Oliveira PC, Groppo FC, Meechan JG, et al. Anesthetic efficacy of 3 volumes of lidocaine with epinephrine in maxillary infiltration anesthesia. Anesth Prog. 2008;55(2):29–34.
14. Sugao H, Yamazaki S, Shiozawa H, Yano K. Taste masking of bitter drug powder without loss of bioavailability by heat treatment of wax-coated microparticles. J Pharm Sci. 1998;87(1):96–100.
15. Gould S, Scott RC. 2-hydroxypropyl-β-cyclodextrin (HP-β-CD): a toxicology review. Food Chem Toxicol. 2005;43(10):1451–9.
16. de Araujo DR, Tsuneda SS, Cereda CM, Del GFCF, Prete PS, Fernandes SA, et al. Development and pharmacological evaluation of ropivacaine-2-hydroxypropyl-beta-cyclodextrin inclusion complex. Euro J Pharm Sci: Offic J Euro Fed Pharm Sci. 2008;33(1):60–71.
17. Kurkov SV, Loftsson T. Cyclodextrins. Int J Pharm. 2013;453(1):167–80.
18. Strickley RG. Solubilizing excipients in oral and injectable formulations. Pharm Res. 2004;21(2):201–30.
19. Tatai A, Aigner Z, Erős I, Kata M. Preparation and investigation of mixtures containing lidocaine base and β-cyclodextrin. J Incl Phenom Macrocycl Chem. 2007;59(1–2):105–13.
20. da Silva LFJS, do Carmo FA, de Almeida Borges VR, Monteiro LM, Rodrigues CR, Cabral LM, et al. Preparation and evaluation of lidocaine hydrochloride in cyclodextrin inclusion complexes for development of stable gel in association with chlorhexidine gluconate for urogenital use. Int J Nanomedicine. 2011;6.
21. Moraes CM, Abrami P, de Araujo DR, Braga AF, Issa MG, Ferraz HG, et al. Characterization of lidocaine: hydroxypropyl-β-cyclodextrin inclusion complex. J Incl Phenom Macrocycl Chem. 2007;57(1–4):313–6.
22. Rowe RC, Sheskey PJ, Weller PJ. Handbook of pharmaceutical excipients: Pharmaceutical Press; 2003.
23. Higuchi T, Connors KA. Phase-solubility techniques. Adv Anal Chem Instrum. 1965;4(2):117–212.
24. Liu X, Lin HS, Thenmozhiyal JC, Chan SY, Ho PC. Inclusion of acitretin into cyclodextrins: phase solubility, photostability, and physicochemical characterization. J Pharm Sci. 2003;92(12):2449–57.
25. Li P, Tabibi SE, Yalkowsky SH. Combined effect of complexation and pH on solubilization. J Pharm Sci. 1998;87(12):1535–7.
26. Gebauer MG, McClure AF, Vlahakis TL. Stability indicating HPLC method for the estimation of oxycodone and lidocaine in rectal gel. Int J Pharm. 2001;223(1):49–54.
27. McLure HA, Rubin AP. Review of local anaesthetic agents. Minerva Anestesiol. 2005;71(3):59–74.
28. Bergström CA, Luthman K, Artursson P. Accuracy of calculated pH-dependent aqueous drug solubility. Eur J Pharm Sci. 2004;22(5):387–98.
29. Cassens J, Prudic A, Ruether F, Sadowski G. Solubility of pharmaceuticals and their salts as a function of pH. Ind Eng Chem Res. 2013;52(7):2721–31.
30. Higuchi TKAC. Phase-solubility techniques. Adv Anal Chem Inst. 1965;4:117–212.
31. Loftsson T, Brewster ME. Cyclodextrins as functional excipients: methods to enhance complexation efficiency. J Pharm Sci. 2012;101(9):3019–32.
32. Malamed SF, Gagnon S, Leblanc D. A comparison between articaine HCl and lidocaine HCl in pediatric dental patients. Pediatr Dent. 2000;22(4):307–11.
33. Constantin M, Bucatariu S, Harabagiu V, Ascenzi P, Fundueanu G. Do cyclodextrins bound to dextran microspheres act as sustained delivery systems of drugs? Int J Pharm. 2014;469(1):1–9.
34. Patel AR, Vavia PR. Preparation and evaluation of taste masked famotidine formulation using drug/beta-cyclodextrin/polymer ternary complexation approach. AAPS PharmSciTech. 2008;9(2):544–50.
35. Sinha VR, Anitha R, Ghosh S, Nanda A, Kumria R. Complexation of celecoxib with beta-cyclodextrin: characterization of the interaction in solution and in solid state. J Pharm Sci. 2005;94(3):676–87.
36. Stuart BH. Infrared Spectroscopy: Fundamentals and Applications: Wiley; 2004.
37. Schneider HJ, Hacket F, Rudiger V, Ikeda H. NMR studies of cyclodextrins and cyclodextrin complexes. Chem Rev. 1998;98(5):1755–86.
38. Costa P, Sousa Lobo JM. Modeling and comparison of dissolution profiles. Eur J Pharm Sci. 2001;13(2):123–33.
39. Gohel M, Sarvaiya K, Shah A, Brahmbhatt B. Mathematical approach for the assessment of similarity factor using a new scheme for calculating weight. Indian J Pharm Sci. 2009;71(2):142.
40. Legin A, Rudnitskaya A, Lvova L, Vlasov Y, Di Natale C, D’Amico A. Evaluation of Italian wine by the electronic tongue: recognition, quantitative analysis and correlation with human sensory perception. Anal Chim Acta. 2003;484(1):33–44.
41. Kobayashi Y, Habara M, Ikezazki H, Chen R, Naito Y, Toko K. Advanced taste sensors based on artificial lipids with global selectivity to basic taste qualities and high correlation to sensory scores. Sensors. 2010;10(4):3411–43. doi:10.3390/s100403411.
42. Dyminski DS, Paterno LG, Takeda HH, Bolini HMA, Mattoso LHC, Cândido LMB. Correlation between human panel and electronic tongue responses on the analysis of commercial sweeteners. Sens Lett. 2006;4(4):403–8.
43. Ciosek P, Wroblewski W. Sensor arrays for liquid sensing–electronic tongue systems. Anal. 2007;132(10):963–78.
44. Woertz K, Tissen C, Kleinebudde P, Breitkreutz J. Taste sensing systems (electronic tongues) for pharmaceutical applications. Int J Pharm. 2011;417(1):256–71.